LGALS3 and Huntington disease: Although galectin-3 assay has been used to assess prognosis of chronic HF and the prognostic utility of galectin-3 has been further demonstrated in other populations, [1, 14] its prognostic value in maintenance HD patients remains limited and inconsistent [1, 15–17].